GeneDx Holdings Corp. WGS

Rank #2361 · Nasdaq · $2.1B market cap

Audited by ERNST & YOUNG LLP, no going-concern flag in the latest filing.

Score

22.0

P/E

-11.7

P/B

8.08

ROE

-69.3%

Op. Margin

-89.2%

Debt Ratio

69%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -11.7x, P/B 8.08x. Ranks in the top 80% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -69.3%. Ranks in the top 90% of the universe.

Safety ★★★★☆

Good

Debt ratio 69%. Ranks in the top 29% of the universe.

Growth ★★☆☆☆

Weak

Revenue growth of 0.0% year over year. Ranks in the top 64% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2020	–	–	–	$0.0B	–	312
2021	$0.2B	$-0.0B	$-0.0B	$-0.1B	-15.5	-442
2022	$0.2B	$-0.2B	$-0.2B	$-0.1B	-134.9	-187
2023	$0.2B	$-0.7B	$-0.5B	$0.4B	-284.5	61
2024	$0.2B	$-0.2B	$-0.2B	$0.3B	-89.2	75
2025	$0.2B	$-0.2B	$-0.2B	$0.3B	-89.2	69